Research shows that the dysregulation of the IL-6/STAT3 signaling pathway mediates lung cancer cell proliferation and invasion, and the suppression of the IL-6/STAT3 pathway prevents the progression of lung cancer (29). This evidence concerns the gene IL6 and lung carcinoma.